OTC Contraceptive App Has US Approval As Claims Are Scrutinized In Sweden, UK
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
UK authority advises Natural Cycles Nordic to discontinue an ad claim its contraceptive app is “highly accurate” because it is not based on "typical" use. Sweden is investigating the firm due to the app's failure rate, but in the US, FDA recently approved it.
You may also be interested in...
Maker Of First OTC Birth Control App Approved In US Questions Clearance Of Competitor's Product
FDA cleared Clue as second OTC app with a birth control indication to reach market but the company making the first app the agency cleared questions whether Clue is as effective and says a more extensive evaluation of Clue is needed.
Clearblue Connects Peak Fertility Data To Smartphone App
P&G's connected Clearblue tracks a user’s personal hormone profile and sends data to a smartphone, typically alerting on the four or more best days to get pregnant, providing a window into fertility two days longer than other ovulation testing brands, the firm says.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.